Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. May 10, 2014; 5(2): 86-92
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.86
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.86
Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB
Lucas Minig, María Guadalupe Patrono, Gynecologic Oncology Program, Clara Campal Comprehensive Cancer Center, HM Hospitales, 28050 Madrid, Spain
Nuria Romero, Juan Francisco Rodríguez Moreno, Jesús Garcia-Donas, Gynecologic Oncology Program, Medical Oncology Department, Clara Campal Comprehensive Cancer Center, HM Hospitales, 28050 Madrid, Spain
Author contributions: Minig L, Patrono MG and Romero N performed the literature review and wrote the manuscript; Minig L, Rodríguez Moreno JF and Garcia-Donas J revised the manuscript.
Correspondence to: Lucas Minig, MD, PhD, Gynecology Oncology Program, Clara Campal Comprehensive Cancer Center, HM Hospitales, Calle Oña 10, 28050 Madrid, Spain. lucasminig@yahoo.com
Telephone: +34-61-6952439 Fax: +34-91-2110119
Received: December 24, 2013
Revised: January 22, 2014
Accepted: April 16, 2014
Published online: May 10, 2014
Revised: January 22, 2014
Accepted: April 16, 2014
Published online: May 10, 2014
Core Tip
Core tip: There is no currenty demonstrated the best option of treatment for women with locally advanced cervical cancer Federation of Gynecology and Obstetrics stage IB2-IIB. This article describe the evidence as well as the advantages and disadvantages of the main strategies of treatment.